Oregon Health & Science UniversityStaff Scientist Oregon Health & Science UniversityStaff ScientistPortland, OregonConduct advanced research in gamete, embryo, stem cell, and molecular biology, including gamete and embryo micromanipulation; in vitro gametogenesis (IVG) via somatic cell nuclear transfer (SCNT); genome editing and gene correction in gametes, embryos, and cultured cells; mitochondrial replacement therapy (MRT); induced pluripotent stem cell (iPSC) and embryonic stem cell (ESC) derivation, culture, and differentiation. Department Overview: The incumbent will provide advanced scientific expertise in genetics, epigenetics, transcriptomics, genome editing, sequencing technologies, and bioinformatics to support both research and clinical initiatives at the Center for Embryonic Cell and Gene Therapy (CECGT).
Oregon Health & Science UniversityInformatician 3 Oregon Health & Science UniversityInformatician 3Portland, OregonKey duties include independently designing, developing, and executing gene editing, sequencing analyses and computational workflows, as well as building and maintaining bioinformatics pipelines, tools, and software for the analysis of high-throughput sequencing data derived from research participants, gametes, preimplantation embryos, and pluripotent stem cells. Independently design, develop, and implement computational tools, pipelines, workflows, and software packages to discover, analyze, and annotate genomic information from high-throughput sequencing data, including bulk and single-cell datasets derived from research participants, gamete donors, gametes, preimplantation embryos, and pluripotent stem cells.
Oregon Health & Science UniversityNewPostdoctoral Scholar Oregon Health & Science UniversityPostdoctoral ScholarPortland, OregonHosseini MH, Kurtz SE, Abdelhamed S, Mahmood S, Davare, MA, Kaempf A, Elferich J, McDermott JE, Liu T, Payne SH, Shinde U, Rodland KD, Mori M, Druker BJ, Singer JK, Agarwal Inhibition of interleukin-1 receptor-associated kinase-1 is a therapeutic strategy for acute myeloid leukemia subtypes. The OHSU Knight Cancer Institute is a pioneer in personalized cancer treatment and research, led by Dr. Brian Druker, whose development of Gleevec transformed Chronic Myeloid Leukemia from a fatal disease to a manageable one and proved that targeted therapies can work.
Centrillion Technologies, Inc.Laboratory Technologist Centrillion Technologies, Inc.Laboratory TechnologistHillsboro, OregonMolecular Vision Laboratory (MVL), a CLIA-certified clinical service laboratory/molecular diagnostic laboratory based in Hillsboro, Oregon, is working on rare genetic conditions with the focus on eye diseases. MVL is part of Centrillion Biosciences, which has advanced research laboratories in US, China, and Taiwan for conducting research, development and commercialization of novel technologies in bioinformatics, genomics, chemistry, biochemistry, and molecular biology.